Mark Saad is listed as an executive officer and director on 4 SEC Form D filings by 2 issuers between Feb 2016 and Dec 2020: BIRD ROCK BIO, INC. (La Jolla, CA — industry reported as "Other" — 2016–2017; $39.9M reported sold to 8 investors) and Presidium Health Corp (San Diego, CA — other health care — 2019–2020; $5.02M reported sold to 21 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 4 years. Across those companies the filings report $44.9M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Mark Saad and found 2 differences: Form D filed 18 days after the first sale; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.